Tetrandrine could downregulate the expression of GLUT1 in human hepatocyte carcinoma HepG2 cells, thereby decreasing the glucose uptake to cancer cells and inducing apoptosis (Yubin et al., 2019). Here, SLC2A1 is linked to cancer.